IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom

Seizure

Volumn 21, Issue 3, 2012, Pages 194-197

  Stockhammer, Florian ^a,b   Misch, Martin ^c   Helms, Hans Joachim ^a   Lengler, Ulrike ^d   Prall, Friedrich ^b   Von Deimling, Andreas ^e,f   Hartmann, Christian ^g  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Astrocytoma; Isocitrate dehydrogenase; Localization; Mutation; Seizure

Indexed keywords

ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE ISOENZYME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BIOPSY TECHNIQUE; BRAIN CORTEX; CANCER GRADING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; GENE MUTATION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULA; PRIORITY JOURNAL; SEIZURE; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; RETROSPECTIVE STUDIES; SEIZURES; YOUNG ADULT;

EID: 84858082359     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2011.12.007     Document Type: Article

References (37)

1. E.F. Chang, M.B. Potts, G.E. Keles, K.R. Lamborn, S.M. Chang, and N.M. Barbaro Seizure characteristics and control following resection in 332 patients with low-grade gliomas Journal of Neurosurgery 108 2008 227 235 (Pubitemid 351213284)
2. M.S. van Breemen, E.B. Wilms, and C.J. Vecht Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurology 6 2007 421 430 (Pubitemid 46551867)
3. D. Kurzwelly, U. Herrlinger, and M. Simon Seizures in patients with low-grade gliomas - incidence, pathogenesis, surgical management, and pharmacotherapy J.D. Pickard, N. Akalan, V. Benes Jr. C. Di Rocco, V.V. Dolenc, J. Lobo Antunes, J. Schramm, M. Sindou, Advances and technical standards in neurosurgery 2009 Springer Wien, New York 81 111
4. A. Beaumont, and I.R. Whittle The pathogenesis of tumour associated epilepsy Acta Neurochirurgica (Wien) 142 2000 1 15 (Pubitemid 30068270)
5. A. Pace, L. Bove, P. Innocenti, A. Pietrangeli, C.M. Carapella, and P. Oppido Epilepsy and gliomas: incidence and treatment in 119 patients Journal of Experimental and Clinical Cancer Research 17 1998 479 482 (Pubitemid 29083423)
6. J. Balss, J. Meyer, W. Mueller, A. Korshunov, C. Hartmann, and A. von Deimling Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathologica (Berl) 116 2008 597 602
7. C. Hartmann, J. Meyer, J. Balss, D. Capper, W. Mueller, and A. Christians Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas Acta Neuropathologica (Berl) 118 2009 469 474
8. L. Dang, D.W. White, S. Gross, B.D. Bennett, M.A. Bittinger, and E.M. Driggers Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 2009 739 744
9. S. Kolker, V. Pawlak, B. Ahlemeyer, J.G. Okun, F. Horster, and E. Mayatepek NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria European Journal of Neuroscience 16 2002 21 28 (Pubitemid 35463594)
10. W.J. Craigen, C. Jakobs, E.A. Sekul, M.L. Levy, K.M. Gibson, and I.J. Butler D-2-hydroxyglutaric aciduria in neonate with seizures and CNS dysfunction Pediatric Neurology 10 1994 49 53
11. S. Saidha, S. Murphy, P. McCarthy, P.D. Mayne, and M. Hennessy L-2-hydroxyglutaric aciduria diagnosed in an adult presenting with acute deterioration Journal of Neurology 257 2010 146 148
12. M. Labussiere, A. Idbaih, X.W. Wang, Y. Marie, B. Boisselier, and C. Falet All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 Neurology 74 2010 1886 1890
13. D.N. Louis, H. Ohgaki, O.D. Wiestler, and W.K. Cavenee WHO classification of tumours of the central nervous system 4 ed. 2007 IARC Press Lyon
14. R.S. Fisher, W. van Emde Boas, W. Blume, C. Elger, P. Genton, and P. Lee Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) Epilepsia 46 2005 470 472 (Pubitemid 40470667)
15. D. Capper, S. Weissert, J. Balss, A. Habel, J. Meyer, and D. Jager Characterization of R132H mutation-specific idh1 antibody binding in brain tumors Brain Pathology 2009
16. H.J. Dubbink, W. Taal, R. van Marion, J.M. Kros, I. van Heuvel, and J.E. Bromberg IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide Neurology 73 2009 1792 1795
17. M.B. Potts, J.S. Smith, A.M. Molinaro, and M.S. Berger Natural history and surgical management of incidentally discovered low-grade gliomas Journal of Neurosurgery 2011 epub ahead of print
18. R.A. Prayson, J. Fong, and I. Najm Coexistent pathology in chronic epilepsy patients with neoplasms Modern Pathology 23 2010 1097 1103
19. W. Mueller, C. Hartmann, A. Hoffmann, W. Lanksch, J. Kiwit, and J. Tonn Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets American Journal of Pathology 161 2002 313 319 (Pubitemid 34760797)
20. N. Sanai, M.Y. Polley, and M.S. Berger Insular glioma resection: assessment of patient morbidity, survival, and tumor progression Journal of Neurosurgery 112 2010 1 9
21. M. Simon, G. Neuloh, M. von Lehe, B. Meyer, and J. Schramm Insular gliomas: the case for surgical management Journal of Neurosurgery 110 2009 685 695
22. J.D. Olson, E. Riedel, and L.M. DeAngelis Long-term outcome of low-grade oligodendroglioma and mixed glioma Neurology 54 2000 1442 1448 (Pubitemid 30210463)
23. F. Stockhammer, A. von Deimling, and F.K. van Landeghem Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II Histopathology 54 2009 241 247
24. H. Jefferies, J. Coster, A. Khalil, J. Bot, R.D. McCauley, and J.C. Hall Glutathione ANZ Journal of Surgery 73 2003 517 522 (Pubitemid 37000024)
25. H. Sontheimer Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage Trends in Neuroscience 26 2003 543 549 (Pubitemid 37176909)
26. Z.J. Reitman, G. Jin, E.D. Karoly, I. Spasojevic, J. Yang, and K.W. Kinzler Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome 108 Proceedings of the National Academy of Sciences United States of America 2011 3270 3275
27. X.Y. Lian, and J.L. Stringer Inhibition of aconitase in astrocytes increases the sensitivity to chemical convulsants Epilepsy Research 60 2004 41 52 (Pubitemid 38981760)
28. J.O. Willoughby, L. Mackenzie, M. Broberg, A.E. Thoren, A. Medvedev, and N.R. Sims Fluorocitrate-mediated astroglial dysfunction causes seizures The Journal of Neuroscience Research 74 2003 160 166 (Pubitemid 37176679)
29. L. De Meirleir Defects of pyruvate metabolism and the Krebs cycle Journal of Child Neurology 17 Suppl 3 2002 [3S26-33;discussion 23S33-24]
30. A. Pace, A. Vidiri, E. Galie, M. Carosi, S. Telera, and A.M. Cianciulli Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Annals of Oncology 14 2003 1722 1726 (Pubitemid 38029042)
31. M. Brada, L. Viviers, C. Abson, F. Hines, J. Britton, and S. Ashley Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas Annals of Oncology 14 2003 1715 1721 (Pubitemid 38029041)
32. M.P. Frenay, D. Fontaine, F. Vandenbos, and C. Lebrun First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas European Journal of Neurology 12 2005 685 690 (Pubitemid 41297830)
33. I.R. Whittle, and A. Beaumont Seizures in patients with supratentorial oligodendroglial tumours clinicopathological features and management considerations Acta Neurochirurgica (Wien) 135 1995 19 24
34. H.W. Chin, J.J. Hazel, T.H. Kim, I. Oligodendrogliomas, and J.H. Webster A clinical study of cerebral oligodendrogliomas Cancer 45 1980 1458 1466
35. Y.H. Kim, S. Nobusawa, M. Mittelbronn, W. Paulus, B. Brokinkel, and K. Keyvani Molecular classification of low-grade diffuse gliomas American Journal of Pathology 177 2010 2708 2714
36. G. Bauman, K. Lote, D. Larson, L. Stalpers, C. Leighton, and B. Fisher Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis International Journal of Radiation Oncology Biology Physics 45 1999 923 929 (Pubitemid 29525456)
37. C. Leighton, B. Fisher, G. Bauman, S. Depiero, L. Stitt, and D. MacDonald Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation Journal of Clinical Oncology 15 1997 1294 1301 (Pubitemid 27167360)